Hypotension Prediction Index Study (HPI Study)
Research payments
$2,311,819
Through program year 2025, $2,311,819 in research payments was reported against Hypotension Prediction Index Study (HPI Study), across 68 payments.
- Paid by (largest first)
- Edwards Lifesciences Corporation; Becton, Dickinson and Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $95,284 | 1 |
| 2022 | Research | $250 | 1 |
| 2021 | Research | $213,524 | 16 |
| 2020 | Research | $2,002,762 | 50 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Drover Stanford, CA Named on 17 payments
- Lingzhong Meng New Haven, CT Named on 14 payments
- Gebhard Wagener New York, NY Named on 5 payments
- Xiaodong Bao Methuen, MA Named on 5 payments
- Sydney Rose Portland, OR Named on 4 payments
- Donald Penning Denver, CO Named on 4 payments
- Kamal Maheshwari Cleveland, OH Named on 4 payments
- Karen Domino Seattle, WA Named on 2 payments
- Mitchell Weinstein Philadelphia, PA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.